14,15-epoxy-5,8,11-eicosatrienoic acid has been researched along with Chronic Kidney Failure in 1 studies
14,15-epoxy-5,8,11-eicosatrienoic acid: RN given refers to cpd without isomeric designation
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Smith, HE | 1 |
| Jones, JP | 1 |
| Kalhorn, TF | 1 |
| Farin, FM | 1 |
| Stapleton, PL | 1 |
| Davis, CL | 1 |
| Perkins, JD | 1 |
| Blough, DK | 1 |
| Hebert, MF | 1 |
| Thummel, KE | 1 |
| Totah, RA | 1 |
1 other study available for 14,15-epoxy-5,8,11-eicosatrienoic acid and Chronic Kidney Failure
| Article | Year |
|---|---|
Role of cytochrome P450 2C8 and 2J2 genotypes in calcineurin inhibitor-induced chronic kidney disease.
Topics: 8,11,14-Eicosatrienoic Acid; Arachidonic Acid; Aryl Hydrocarbon Hydroxylases; Calcineurin Inhibitors | 2008 |